SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-150192
Filing Date
2020-05-22
Accepted
2020-05-22 16:44:50
Documents
14
Period of Report
2020-05-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d860102d8k.htm   iXBRL 8-K 31524
2 EX-99.1 d860102dex991.htm EX-99.1 7806
  Complete submission text file 0001193125-20-150192.txt   203899

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pfe-20200522.xsd EX-101.SCH 4525
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pfe-20200522_def.xml EX-101.DEF 13709
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pfe-20200522_lab.xml EX-101.LAB 22718
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pfe-20200522_pre.xml EX-101.PRE 14677
9 EXTRACTED XBRL INSTANCE DOCUMENT d860102d8k_htm.xml XML 6259
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-03619 | Film No.: 20906567
SIC: 2834 Pharmaceutical Preparations